Abstract:Dimethylarsinic acid (DMA(V)) is carcinogenic to the rat urinary bladder when administered at high doses in the diet or drinking water. At a dietary dose of 100 ppm (microg/g), it produces cytotoxicity within 6 h and increased proliferation (hyperplasia) by 7 days of administration. We hypothesize that formation of the reactive organic intermediate dimethylarsinous acid (DMA(III)) is involved in the induction of the cytotoxicity. To evaluate the possibility that DMA(V) administration produces urothelial toxicity and regeneration by the formation of trivalent arsenicals, 2,3-dimercaptopropane-1-sulfonic acid (DMPS, 5600 ppm), a chelator of trivalent arsenicals, was co-administered with DMA(V) (100 ppm) for 2 weeks to groups of female Fischer F344 rats. Based on light and scanning electron microscopy, and bromodeoxyuridine labeling index, DMA(V) produced cytotoxicity and regenerative hyperplasia of the urothelium which was inhibited by co-administration with DMPS. The major forms of arsenic in the 24-h urine of rats administered DMA(V) were high concentrations of DMA(V) (66.4 +/- 2.7 microM) itself and the pentavalent organic arsenical trimethylarsine oxide (TMAO) (73.2 +/- 9.5 microM). Co-administration with DMPS led to an increase in DMA(V) (507 +/- 31 microM) with a decrease in TMAO (2.8 +/- 0.4 microM) excretion. The formation of TMAO from DMA(V) mechanistically suggests formation of the intermediate trivalent metabolite, DMA(III). In a second experiment evaluating fresh void urines collected on study days 1, 71, and 175, we detected DMA(III) in the urine of DMA(V) and DMA(V) plus DMPS-treated rats at approximately micromolar concentrations. Using rat (MYP3) and human (1T1) urothelial cells, cytotoxicity for trivalent arsenicals, sodium arsenite, monomethylarsonous acid (MMA(III)), and DMA(III) was demonstrated at 0.4-4.8 microM concentrations, whereas MMA(V), DMA(V), and TMAO were cytotoxic at millimolar concentrations. The presence of DMA(III) at micromolar concentrations in the urine of rats fed 100 ppm DMA(V) suggests that DMA(III) produced in vivo may be involved in the toxic effects in the rat urinary bladder after dietary administration of DMA(V).

Arsenic-induced bladder cancer in an animal model

Distribution And Speciation Of Arsenic After Intravenous Administration Of Monomethylmonothioarsonic Acid In Rats

Dimethylarsinic acid (DMA(V) ) changed the expressions of proliferative related factors and secretion of inflammatory cytokines in rat bladder.

The Distribution in Tissues and Urine of Arsenic Metabolites after Subchronic Exposure to Dimethylarsinic Acid (DMA V ) in Rats

Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat

Mitochondria Are the Main Target Organelle for Trivalent Monomethylarsonous Acid (Mmaiii)-Induced Cytotoxicity

Effects of Inorganic Arsenic on the Rat and Mouse Urinary Bladder

DMA(V) in Drinking Water Activated NF-κB Signal Pathway and Increased TGF-β and IL-1β Expressions in Bladder Epithelial Cells of Rats.

Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium.

Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells.

Toxicity of dimethylmonothioarsinic acid toward human epidermoid carcinoma A431 cells

DMAVin Drinking Water Activated NF-κB Signal Pathway and Increased TGF-βand IL-1βExpressions in Bladder Epithelial Cells of Rats

DNA Methylation Aberrations in Dimethylarsinic Acid-Induced Bladder Carcinogenesis

Dimethylarsine Likely Acts As a Mouse-Pulmonary Tumor Initiator Via the Production of Dimethylarsine Radical And/or Its Peroxy Radical.

Formation of dimethylthioarsenicals in red blood cells.

Toxicological properties of the thiolated inorganic arsenic and arsenosugar metabolite thio-dimethylarsinic acid in human bladder cells

Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2'-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis.

Release of apoptotic cytochrome C from mitochondria by dimethylarsinous acid occurs through interaction with voltage-dependent anion channel in vitro.

The Urinary Excretion of Arsenic Metabolites after A Single Oral Administration of Dimethylarsinic Acid to Rats

A Major Human Arsenic Metabolite, Dimethylarsinic Acid, Requires Reduced Glutathione To Induce Apoptosis

Evaluation of the carcinogenicity of inorganic arsenic